{"id":"W2763948152","doi":"","title":"Use of Obinutuzumab for B-cell Malignancies","year":2017,"lang":"en","type":"article","venue":"Medical Research Archives","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Obinutuzumab; Rituximab; CD20; Medicine; Chronic lymphocytic leukemia; Monoclonal antibody; Oncology; Monoclonal antibody therapy; Lymphoma; Monoclonal; Internal medicine; Immunology; Leukemia; Antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001128394,0.0003102536,0.0004387638,0.0009972422,0.0003096705,0.0008277759,0.0003318036,0.0004154253,0.002183192],"category_scores_gemma":[0.002776377,0.00009498507,0.0005510332,0.001220325,0.0003082996,0.0004841888,0.0003663418,0.0005736822,0.0004884921],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006454016,"about_ca_system_score_gemma":0.0006553031,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005908464,"about_ca_topic_score_gemma":0.0009153002,"domain_scores_codex":[0.9992946,0.0002196018,0.0001114012,0.0001097745,0.0001757775,0.00008870617],"domain_scores_gemma":[0.99845,0.000705538,0.0004260794,0.0001449863,0.0001416498,0.0001316708],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.003137155,0.0003476114,0.0384178,0.001719082,0.0005139167,0.001944302,0.0001706035,0.0007512281,0.01336347,0.001157279,0.002169982,0.9363075],"study_design_scores_gemma":[0.001693889,0.01174601,0.1739496,0.003451544,0.004037781,0.03624064,0.0002775163,0.001352692,0.07477523,0.00242218,0.6899709,0.00008193152],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.3183752,0.654748,0.003293834,0.002119344,0.0004965074,0.0001832366,0.0009292635,0.0001139805,0.01974068],"genre_scores_gemma":[0.8674653,0.1222772,0.003198081,0.001698976,0.0007312773,0.00009661219,0.001024097,0.00005589485,0.003452442],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.002183192,"threshold_uncertainty_score":0.007303536,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1962971642212667,"score_gpt":0.4476604100344491,"score_spread":0.2513632458131824,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}